{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:25:20Z","timestamp":1777386320021,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2017T100186"],"award-info":[{"award-number":["2017T100186"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["20170540858"],"award-info":[{"award-number":["20170540858"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["2017LQN05"],"award-info":[{"award-number":["2017LQN05"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Career Development Support Plan for Young and Middle-aged Teachers in Shenyang Pharmaceutical University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejmech.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T13:16:17Z","timestamp":1522847777000},"page":"376-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties"],"prefix":"10.1016","volume":"151","author":[{"given":"Xu","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runwei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoda","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiming","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-4619","authenticated-orcid":false,"given":"Dahong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.04.009_bib1","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/molecules14051852","article-title":"Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa","volume":"14","author":"Jiang","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.04.009_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2014.05.002","article-title":"Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine","volume":"81","author":"Huang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopha.2017.12.017","article-title":"Blood-brain barrier permeability and neuroprotective effects of three main alkaloids from the fruits of Euodia rutaecarpa with MDCK-pHaMDR cell monolayer and PC12 cell line","volume":"98","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2018.04.009_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.canlet.2012.09.019","article-title":"Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells","volume":"328","author":"Yang","year":"2013","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2018.04.009_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.05.064","article-title":"Co-delivery of evodiamine and rutaecarpine in a microemulsion-based hyaluronic acid hydrogel for enhanced analgesic effects on mouse pain models","volume":"528","author":"Zhang","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2018.04.009_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.fitote.2009.09.012","article-title":"Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation","volume":"81","author":"Hu","year":"2010","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2018.04.009_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12944-017-0628-x","article-title":"Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats","volume":"16","author":"Zhou","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejmech.2018.04.009_bib8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s10753-017-0546-0","article-title":"Evodiamine inhibits zymosan-induced inflammation in\u00a0vitro and in\u00a0vivo: inactivation of NF-\u03baB by inhibiting I\u03baB\u03b1 phosphorylation","volume":"40","author":"Fan","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.ejmech.2018.04.009_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jff.2017.07.042","article-title":"Daily chemical evodiamine from Chinese prickly ash attenuates osteoclast differentiation through RANKL induced NFAT pathways","volume":"37","author":"Jiang","year":"2017","journal-title":"J.\u00a0Funct. Foods"},{"key":"10.1016\/j.ejmech.2018.04.009_bib10","first-page":"1","article-title":"Evodiamine reduces caffeine-induced sleep disturbances and excitation in mice","author":"Ko","year":"2018","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.ejmech.2018.04.009_bib11","first-page":"145","article-title":"Evodiamine ameliorates liver fibrosis in rats via TGF-\u03b21\/Smad signaling pathway","volume":"72","author":"Yang","year":"2018","journal-title":"J.\u00a0Nat. Med."},{"key":"10.1016\/j.ejmech.2018.04.009_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11010-017-2956-6","article-title":"Evodiamine attenuates TGF-\u03b21-induced fibroblast activation and endothelial to mesenchymal transition","volume":"430","author":"Wu","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib13","article-title":"Evodiamine inhibits angiotensin \u2161-induced rat cardiomyocyte hypertrophy","author":"He","year":"2017","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.ejmech.2018.04.009_bib14","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1021\/acs.jmedchem.5b00910","article-title":"Scaffold diversity inspired by the natural product evodiamine: discovery of highly potent and multitargeting antitumor agents","volume":"58","author":"Wang","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib15","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1021\/jm300605m","article-title":"New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations","volume":"55","author":"Dong","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib16","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1021\/jm100387d","article-title":"Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents","volume":"53","author":"Dong","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-3-319-41342-6_14","article-title":"Evodiamine and its role in chronic diseases","volume":"929","author":"Tan","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2017.02.017","article-title":"Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma","volume":"485","author":"Yang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2018.04.009_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.21873\/anticanres.11428","article-title":"Evodiamine induces cell growth arrest, apoptosis and suppresses tumorigenesis in human urothelial cell carcinoma cells","volume":"37","author":"Shi","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2018.04.009_bib20","doi-asserted-by":"crossref","first-page":"12572","DOI":"10.1038\/s41598-017-12918-y","article-title":"Cytological assessments and transcriptome profiling demonstrate that evodiamine inhibits growth and induces apoptosis in a renal carcinoma cell line","volume":"7","author":"Yuan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.04.009_bib21","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1007\/s13277-015-3174-z","article-title":"Apoptosis of human non-small-cell lung cancer A549 cells triggered by evodiamine through MTDH-dependent signaling pathway","volume":"36","author":"Zou","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00280-015-2902-9","article-title":"Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in\u00a0vitro via repressing MMP-2 expression","volume":"76","author":"Peng","year":"2015","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.phymed.2012.02.003","article-title":"Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells","volume":"19","author":"Pan","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2018.04.009_bib24","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3892\/ijmm.2015.2383","article-title":"Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells","volume":"36","author":"Wen","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2018.04.009_bib25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ptr.5359","article-title":"In\u00a0vitro assessment of the anticancer potential of evodiamine in human oral cancer cell lines","volume":"29","author":"Sachita","year":"2015","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2018.04.009_bib26","doi-asserted-by":"crossref","first-page":"27411","DOI":"10.3390\/ijms161126031","article-title":"Evodiamine induces apoptosis and inhibits migration of HCT-116 human colorectal cancer cells","volume":"16","author":"Zhao","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2018.04.009_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/ijbs.8.1","article-title":"Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K\/Akt pathway","volume":"8","author":"Wei","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2018.04.009_bib28","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.3390\/ijms15023154","article-title":"Evodiamine induces apoptosis and enhances TRAIL-induced apoptosis in human bladder cancer cells through mTOR\/S6K1-mediated downregulation of Mcl-1","volume":"15","author":"Zhang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2018.04.009_bib29","article-title":"Evodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting p-glycoprotein","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.04.009_bib30","doi-asserted-by":"crossref","first-page":"16415","DOI":"10.1038\/srep16415","article-title":"Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells","volume":"5","author":"Zhong","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.04.009_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22071175","article-title":"Evodiamine exerts an anti-Hepatocellular carcinoma activity through a WWOX-dependent pathway","volume":"22","author":"Hu","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.04.009_bib32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3892\/or.2017.5379","article-title":"Effect of evodiamine and berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-\u03b21","volume":"37","author":"Huang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2018.04.009_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/pr.117.014050","article-title":"International union of basic and clinical pharmacology. CII: pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors","volume":"69","author":"Szabo","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2018.04.009_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4433","article-title":"Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter","volume":"14","author":"Wallace","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.04.009_bib35","doi-asserted-by":"crossref","first-page":"186908","DOI":"10.1155\/2015\/186908","article-title":"Role of hydrogen sulfide in ischemia-reperfusion injury","volume":"2015","author":"Wu","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.ejmech.2018.04.009_bib36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/HJH.0000000000001605","article-title":"Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta\/endothelial nitric oxide synthase signaling","volume":"36","author":"Xiao","year":"2018","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.ejmech.2018.04.009_bib37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/ars.2013.5324","article-title":"Hydrogen sulfide and the pathogenesis of atherosclerosis","volume":"20","author":"Mani","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2018.04.009_bib38","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bjp.0706014","article-title":"Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis","volume":"143","author":"Mok","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jmb.2016.12.015","article-title":"Functional and molecular insights of hydrogen sulfide signaling and protein sulfhydration","volume":"429","author":"Sen","year":"2017","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/path.4659","article-title":"Cysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacology","volume":"238","author":"Carter","year":"2016","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.04.009_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-18144-8_12","article-title":"Hydrogen sulfide and cancer","volume":"230","author":"Hellmich","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molcel.2011.10.021","article-title":"Hydrogen sulfide-linked sulfhydration of NF-\u03baB mediates its anti-apoptotic actions","volume":"45","author":"Sen","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2018.04.009_bib44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1248\/bpb.b15-01015","article-title":"Endogenous hydrogen sulfide enhances cell proliferation of human gastric cancer AGS cells","volume":"39","author":"Sekiguchi","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2018.04.009_bib45","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1038\/s41598-017-05457-z","article-title":"Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR\/ERK\/MMP-2 and PTEN\/AKT signaling pathways","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.04.009_bib46","article-title":"Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K\/Akt\/mTOR signaling pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2018.04.009_bib47","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3892\/or.2015.4248","article-title":"Exogenous hydrogen sulfde promotes C6 glioma cell growth through activation of the p38 MAPK\/ERK1\/2-COX-2 pathways","volume":"34","author":"Zhen","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2018.04.009_bib48","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1039\/C4CC00968A","article-title":"Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications","volume":"50","author":"Zhao","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2018.04.009_bib49","article-title":"A\u00a0review of hydrogen sulfide (H2S) donors: chemistry and potential therapeutic applications","author":"Powell","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib50","article-title":"The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in\u00a0vitro and in\u00a0vivo","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.04.009_bib51","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3892\/ijo.2014.2305","article-title":"GYY4137, a hydrogen sulfide (H2S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway","volume":"44","author":"Lu","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib52","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1476-5381.2011.01704.x","article-title":"Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in\u00a0vitro and prevent osteolysis ex\u00a0vivo","volume":"165","author":"Frantzias","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib53","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.jmedchem.6b00184","article-title":"H2S-donating doxorubicins may overcome cardiotoxicity and multidrug resistance","volume":"59","author":"Chegaev","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib54","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1021\/acs.jmedchem.5b00848","article-title":"Discovery of new H2S releasing phosphordithioates and 2,3-dihydro-2-phenyl-2-sulfanylenebenzo[d][1,3,2]oxazaphospholes with improved antiproliferative activity","volume":"58","author":"Feng","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib55","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fphar.2017.00664","article-title":"Recent development of hydrogen sulfide releasing\/stimulating reagents and their potential applications in cancer and glycometabolic disorders","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.009_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2016.10.019","article-title":"ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in\u00a0vivo","volume":"114","author":"Cicco","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2018.04.009_bib57","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.phrs.2016.07.041","article-title":"Hydrogen sulfide-releasing anti-inflammatory drugs for chemoprevention and treatment of cancer","volume":"111","author":"Ianaro","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2018.04.009_bib58","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/mabi.201500156","article-title":"Hydrolysis-sensitive dithiolethione prodrug micelles","volume":"15","author":"Hasegawa","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejmech.2018.04.009_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejmech.2017.06.012","article-title":"Syntheses, toxicities and anti-inflammation of H2S-donors based on non-steroidal anti-inflammatory drugs","volume":"138","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/ja1085723","article-title":"Cysteine-activated hydrogen sulfide (H2S) donors","volume":"133","author":"Zhao","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.04.009_bib61","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1021\/acs.jmedchem.7b00888","article-title":"Iminothioethers as hydrogen sulfide donors: from the gasotransmitter release to the vascular effects","volume":"60","author":"Barresi","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib62","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acs.orglett.7b04005","article-title":"Cyclic acyl disulfides and acyl selenylsulfides as the precursors for persulfides (RSSH), selenylsulfides (RSeSH), and hydrogen sulfide (H2S)","volume":"20","author":"Kang","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.04.009_bib63","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1021\/acs.orglett.7b00858","article-title":"Applications of synthetic organic tetrasulfides as H2S donors","volume":"19","author":"Cerda","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.04.009_bib64","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ejmech.2017.10.068","article-title":"1,2,4-thiadiazolidin-3,5-diones as novel hydrogen sulfide donors","volume":"143","author":"Severino","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib65","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.bmc.2016.05.001","article-title":"Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine","volume":"24","author":"Zhao","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib66","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1016\/j.bmcl.2017.10.014","article-title":"Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity","volume":"27","author":"Hu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.04.009_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2016.02.057","article-title":"Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives","volume":"114","author":"Gon\u00e7alves","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib68","first-page":"573","article-title":"Why target apoptosis in cancer treatment?","volume":"2","author":"Kasibhatla","year":"2003","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.04.009_bib69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/excr.2000.4833","article-title":"The mitochondrion in cell death control: certainties and incognita","volume":"256","author":"Loeffler","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2018.04.009_bib70","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1159\/000471932","article-title":"Exogenous hydrogen sulfde ameliorates diabetes-associated cognitive decline by regulating the mitochondria-mediated apoptotic pathway and IL-23\/IL-17 expression in db\/db mice","volume":"41","author":"Ma","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib71","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J","article-title":"Paclitaxel-induced cell death: where the cell cycle and apoptosis come together","volume":"88","author":"Wang","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2018.04.009_bib72","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1073\/pnas.96.5.2147","article-title":"p53 regulates a G2 checkpoint through cyclin B1","volume":"96","author":"Innocente","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2018.04.009_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s12011-018-1292-3","article-title":"Endogenous hydrogen sulfide promotes apoptosis via mitochondrial pathways in the livers of broilers with selenium deficiency exudative diathesis disease","author":"Zheng","year":"2018","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ejmech.2018.04.009_bib74","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2018.04.009_bib75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejmech.2017.05.018","article-title":"Nitric oxide-releasing derivatives of brefeldin A as potent and highly selective anticancer agents","volume":"136","author":"Tian","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib76","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2017.03.020","article-title":"Scutellarin derivatives as apoptosis inducers: design, synthesis and biological evaluation","volume":"135","author":"Han","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib77","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ejmech.2018.01.069","article-title":"Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: synthesis of promising candidates for anticancer therapeutics","volume":"146","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib78","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejmech.2017.03.027","article-title":"Design, synthesis and biological evaluation of novel nitric oxide-donating protoberberine derivatives as antitumor agents","volume":"132","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib79","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.jmedchem.6b01652","article-title":"A\u00a0novel potent anticancer compound optimized from a natural oridonin scaffold induces apoptosis and cell cycle arrest through the mitochondrial pathway","volume":"60","author":"Xu","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib80","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejmech.2017.04.045","article-title":"Discovery of novel antitumor nitric oxide-donating \u03b2-elemene hybrids through inhibiting the PI3K\/Akt pathway","volume":"135","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib81","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejmech.2017.03.055","article-title":"Design, synthesis, and biological evaluation of NAD(P)H: quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation","volume":"132","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.009_bib82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejmech.2018.02.088","article-title":"Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: design, synthesis and antitumor biological evaluation","volume":"150","author":"Han","year":"2018","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T22:37:07Z","timestamp":1565303827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418303362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":82,"alternative-id":["S0223523418303362"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.009","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}